These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 31302615)

  • 1. Nasal mucosal melanoma as a cause of epistaxis.
    Behranwala R; Loku Waduge BH; Teo B
    BMJ Case Rep; 2019 Jul; 12(7):. PubMed ID: 31302615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent epistaxis leading to diagnosis of primary sinonasal melanoma.
    Tawagi K; Akaraz-Avedissian R; Burman-Solovyeva I
    BMJ Case Rep; 2018 Feb; 2018():. PubMed ID: 29453209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance features of sinonasal melanotic mucosal melanoma.
    Nardi C; Vignoli C; Vannucchi M; Pietragalla M
    BMJ Case Rep; 2019 Jul; 12(7):. PubMed ID: 31337627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dramatic effect of nivolumab against melanoma and immune-related liver toxicity: A detailed histopathological and immunohistochemical analysis of nivolumab-induced liver toxicity.
    Namiki T; Nojima K; Chikazawa S; Iwamoto Y; Otsuki Y; Albusani H; Miura K; Kiyokawa Y; Asakage T; Yokozeki H
    J Dermatol; 2019 May; 46(5):e182-e183. PubMed ID: 30474878
    [No Abstract]   [Full Text] [Related]  

  • 5. Mucosal melanoma of the nasal cavity and paranasal sinuses.
    Gilain L; Houette A; Montalban A; Mom T; Saroul N
    Eur Ann Otorhinolaryngol Head Neck Dis; 2014 Dec; 131(6):365-369. PubMed ID: 24906226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complete response to nivolumab monotherapy in a treatment-naive, BRAF wild-type patient with advanced mucosal melanoma and elevated lactate dehydrogenase: a case report from a phase III trial.
    Ascierto PA; Vanella V; Grimaldi AM; Lucia F; Palla M; Simeone E; Mozzillo N
    Cancer Immunol Immunother; 2016 Nov; 65(11):1395-1400. PubMed ID: 27604993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudoprogression with subsequent complete response and severe thrombocytopenia to checkpoint inhibitor immunotherapy in a patient with advanced mucosal melanoma of the sinonasal cavity.
    Philipp M; Frischhut N; Tschachler A; Steinkohl F; Weinlich G; Schmuth M; Nguyen VA
    Anticancer Drugs; 2018 Oct; 29(9):914-918. PubMed ID: 29952773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case of acute-onset type 1 diabetes induced by long-term immunotherapy with nivolumab in a patient with mucosal melanoma.
    Maekawa T; Okada K; Okada H; Kado S; Kamiya K; Komine M; Murata S; Oka K; Ishibashi S; Ohtsuki M
    J Dermatol; 2019 Dec; 46(12):e463-e464. PubMed ID: 31436330
    [No Abstract]   [Full Text] [Related]  

  • 9. Primary malignant melanoma of the nose: a rare cause of epistaxis in the elderly.
    Tiwari D; Plater M; Partridge R; Weston-Simons J
    Age Ageing; 2005 Nov; 34(6):653-4. PubMed ID: 16267199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial.
    Hodi FS; Chiarion-Sileni V; Gonzalez R; Grob JJ; Rutkowski P; Cowey CL; Lao CD; Schadendorf D; Wagstaff J; Dummer R; Ferrucci PF; Smylie M; Hill A; Hogg D; Marquez-Rodas I; Jiang J; Rizzo J; Larkin J; Wolchok JD
    Lancet Oncol; 2018 Nov; 19(11):1480-1492. PubMed ID: 30361170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response to the Rechallenge With Talimogene Laherparepvec (T-VEC) After Ipilimumab/Nivolumab Treatment in Patient With Cutaneous Malignant Melanoma Who Initially Had a Progression on T-VEC With Pembrolizumab.
    Afzal MZ; Shirai K
    J Immunother; 2019 May; 42(4):136-141. PubMed ID: 30933044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucosal melanoma of the sinonasal tract.
    Ferraro RE; Schweinfurth JM; Highfill GR
    Am J Otolaryngol; 2002; 23(5):321-3. PubMed ID: 12239703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Primary malignant melanoma of the nasal mucosa with orbital involvement. Case report].
    Gallotti M; Gencarelli G; Lancella A; Perinti A
    Acta Otorhinolaryngol Ital; 2002 Aug; 22(4):248-51. PubMed ID: 12379047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereotactic radiosurgery combined with nivolumab or Ipilimumab for patients with melanoma brain metastases: evaluation of brain control and toxicity.
    Minniti G; Anzellini D; Reverberi C; Cappellini GCA; Marchetti L; Bianciardi F; Bozzao A; Osti M; Gentile PC; Esposito V
    J Immunother Cancer; 2019 Apr; 7(1):102. PubMed ID: 30975225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant mucosal melanoma in the nasal cavity: an uncommon cause of epistaxis.
    Lo RH; Chang KP; Chu ST
    J Chin Med Assoc; 2010 Sep; 73(9):496-8. PubMed ID: 20875625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant nivolumab plus ipilimumab or nivolumab monotherapy versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): a randomised, double-blind, placebo-controlled, phase 2 trial.
    Zimmer L; Livingstone E; Hassel JC; Fluck M; Eigentler T; Loquai C; Haferkamp S; Gutzmer R; Meier F; Mohr P; Hauschild A; Schilling B; Menzer C; Kieker F; Dippel E; Rösch A; Simon JC; Conrad B; Körner S; Windemuth-Kieselbach C; Schwarz L; Garbe C; Becker JC; Schadendorf D;
    Lancet; 2020 May; 395(10236):1558-1568. PubMed ID: 32416781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of nivolumab in combination with ipilimumab in Japanese patients with advanced melanoma: An open-label, single-arm, multicentre phase II study.
    Namikawa K; Kiyohara Y; Takenouchi T; Uhara H; Uchi H; Yoshikawa S; Takatsuka S; Koga H; Wada N; Minami H; Hatsumichi M; Asada S; Namba Y; Yamazaki N
    Eur J Cancer; 2018 Dec; 105():114-126. PubMed ID: 30447539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Three cases of mucosal malignant melanoma of the nose and paranasal sinuses].
    Kaymakçi M; Gür OE; Aygenç E; Fidan F; Ozdem C
    Kulak Burun Bogaz Ihtis Derg; 2005; 15(3-4):87-90. PubMed ID: 16340299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Haemangiopericytoma of the nasal cavity as a cause of recurrent epistaxis--case report].
    Kuzniar J; Pazdro-Zastawny K; Sztuka A; Rostkowska-Nadolska B; Jeleń M
    Pol Merkur Lekarski; 2006 Jul; 21(121):65-8. PubMed ID: 17007297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary mucosal melanoma of the nasal cavity: an uncommon cause of epistaxis in the elderly.
    Ferri E; Pavon I; Armato E; Ianniello F
    Otolaryngol Head Neck Surg; 2008 Jun; 138(6):797-8. PubMed ID: 18503860
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.